These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 32715620)

  • 1. Early language measures associated with later psychosis features in 22q11.2 deletion syndrome.
    Solot CB; Moore TM; Crowley TB; Gerdes M; Moss E; McGinn DE; Emanuel BS; Zackai EH; Gallagher S; Calkins ME; Ruparel K; Gur RC; McDonald-McGinn DM; Gur RE
    Am J Med Genet B Neuropsychiatr Genet; 2020 Sep; 183(6):392-400. PubMed ID: 32715620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cognitive decline preceding the onset of psychosis in patients with 22q11.2 deletion syndrome.
    Vorstman JA; Breetvelt EJ; Duijff SN; Eliez S; Schneider M; Jalbrzikowski M; Armando M; Vicari S; Shashi V; Hooper SR; Chow EW; Fung WL; Butcher NJ; Young DA; McDonald-McGinn DM; Vogels A; van Amelsvoort T; Gothelf D; Weinberger R; Weizman A; Klaassen PW; Koops S; Kates WR; Antshel KM; Simon TJ; Ousley OY; Swillen A; Gur RE; Bearden CE; Kahn RS; Bassett AS;
    JAMA Psychiatry; 2015 Apr; 72(4):377-85. PubMed ID: 25715178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurocognitive profile in psychotic versus nonpsychotic individuals with 22q11.2 deletion syndrome.
    Weinberger R; Yi J; Calkins M; Guri Y; McDonald-McGinn DM; Emanuel BS; Zackai EH; Ruparel K; Carmel M; Michaelovsky E; Weizman A; Gur RC; Gur RE; Gothelf D
    Eur Neuropsychopharmacol; 2016 Oct; 26(10):1610-8. PubMed ID: 27524298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Psychosis Spectrum in 22q11.2 Deletion Syndrome Is Comparable to That of Nondeleted Youths.
    Tang SX; Moore TM; Calkins ME; Yi JJ; Savitt A; Kohler CG; Souders MC; Zackai EH; McDonald-McGinn DM; Emanuel BS; Gur RC; Gur RE
    Biol Psychiatry; 2017 Jul; 82(1):17-25. PubMed ID: 27832840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Computerized neurocognitive profile in young people with 22q11.2 deletion syndrome compared to youths with schizophrenia and at-risk for psychosis.
    Goldenberg PC; Calkins ME; Richard J; McDonald-McGinn D; Zackai E; Mitra N; Emanuel B; Devoto M; Borgmann-Winter K; Kohler C; Conroy CG; Gur RC; Gur RE
    Am J Med Genet B Neuropsychiatr Genet; 2012 Jan; 159B(1):87-93. PubMed ID: 22170773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Longitudinal perspectives on the psychosis spectrum in 22q11.2 deletion syndrome.
    Tang SX; Gur RE
    Am J Med Genet A; 2018 Oct; 176(10):2192-2202. PubMed ID: 29048724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Musical auditory processing, cognition, and psychopathology in 22q11.2 deletion syndrome.
    Gao L; Tang SX; Yi JJ; McDonald-McGinn DM; Zackai EH; Emanuel BS; Gur RC; Calkins ME; Gur RE
    Am J Med Genet B Neuropsychiatr Genet; 2018 Dec; 177(8):765-773. PubMed ID: 30444066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Longitudinal study of premorbid adjustment in 22q11.2 deletion (velocardiofacial) syndrome and association with psychosis.
    Radoeva PD; Fremont W; Antshel KM; Kates WR
    Dev Psychopathol; 2017 Feb; 29(1):93-106. PubMed ID: 26864886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The interaction between neurocognitive functioning, subthreshold psychotic symptoms and pharmacotherapy in 22q11.2 deletion syndrome: A longitudinal comparative study.
    Weinberger R; Weisman O; Guri Y; Harel T; Weizman A; Gothelf D
    Eur Psychiatry; 2018 Feb; 48():20-26. PubMed ID: 29331595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting Cognition and Psychosis in Young Adults With 22q11.2 Deletion Syndrome.
    Antshel KM; Fremont W; Ramanathan S; Kates WR
    Schizophr Bull; 2017 Jul; 43(4):833-842. PubMed ID: 27798222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Computer-vision analysis of craniofacial dysmorphology in 22q11.2 deletion syndrome and psychosis spectrum disorders.
    Roalf DR; McDonald-McGinn DM; Jee J; Krall M; Crowley TB; Moberg PJ; Kohler C; Calkins ME; Crow AJD; Fleischer N; Gallagher RS; Gonzenbach V; Clark K; Gur RC; McClellan E; McGinn DE; Mordy A; Ruparel K; Turetsky BI; Shinohara RT; White L; Zackai E; Gur RE
    J Neurodev Disord; 2024 Jun; 16(1):35. PubMed ID: 38918700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychotic symptoms in children and adolescents with 22q11.2 deletion syndrome: Neuropsychological and behavioral implications.
    Debbané M; Glaser B; David MK; Feinstein C; Eliez S
    Schizophr Res; 2006 Jun; 84(2-3):187-93. PubMed ID: 16545541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contribution of congenital heart disease to neuropsychiatric outcome in school-age children with 22q11.2 deletion syndrome.
    Yi JJ; Tang SX; McDonald-McGinn DM; Calkins ME; Whinna DA; Souders MC; Zackai EH; Goldmuntz E; Gaynor JW; Gur RC; Emanuel BS; Gur RE
    Am J Med Genet B Neuropsychiatr Genet; 2014 Mar; 165B(2):137-47. PubMed ID: 24265253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence, course and psychosis-predictive value of negative symptoms in 22q11.2 deletion syndrome.
    Schneider M; Armando M; Schultze-Lutter F; Pontillo M; Vicari S; Debbané M; Eliez S
    Schizophr Res; 2019 Apr; 206():386-393. PubMed ID: 30414720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adolescents at ultra-high risk for psychosis with and without 22q11 deletion syndrome: a comparison of prodromal psychotic symptoms and general functioning.
    Armando M; Girardi P; Vicari S; Menghini D; Digilio MC; Pontillo M; Saba R; Mazzone L; Lin A; Klier CM; Schäfer MR; Amminger GP
    Schizophr Res; 2012 Aug; 139(1-3):151-6. PubMed ID: 22627123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Social cognition in 22q11.2 deletion syndrome and idiopathic developmental neuropsychiatric disorders.
    Jalal R; Nair A; Lin A; Eckfeld A; Kushan L; Zinberg J; Karlsgodt KH; Cannon TD; Bearden CE
    J Neurodev Disord; 2021 Apr; 13(1):15. PubMed ID: 33863277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Olfactory deficits and psychosis-spectrum symptoms in 22q11.2 deletion syndrome.
    Tang SX; Moberg PJ; Yi JJ; Wiemken AS; Dress EM; Moore TM; Calkins ME; McDonald-McGinn DM; Zackai EH; Emanuel BS; Gur RC; Gur RE; Turetsky BI
    Schizophr Res; 2018 Dec; 202():113-119. PubMed ID: 30007867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for the emergence of psychotic disorders in adolescents with 22q11.2 deletion syndrome.
    Gothelf D; Feinstein C; Thompson T; Gu E; Penniman L; Van Stone E; Kwon H; Eliez S; Reiss AL
    Am J Psychiatry; 2007 Apr; 164(4):663-9. PubMed ID: 17403981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subthreshold psychotic symptoms in 22q11.2 deletion syndrome.
    Tang SX; Yi JJ; Moore TM; Calkins ME; Kohler CG; Whinna DA; Souders MC; Zackai EH; McDonald-McGinn DM; Emanuel BS; Bilker WB; Gur RC; Gur RE
    J Am Acad Child Adolesc Psychiatry; 2014 Sep; 53(9):991-1000.e2. PubMed ID: 25151422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A longitudinal examination of the psychoeducational, neurocognitive, and psychiatric functioning in children with 22q11.2 deletion syndrome.
    Hooper SR; Curtiss K; Schoch K; Keshavan MS; Allen A; Shashi V
    Res Dev Disabil; 2013 May; 34(5):1758-69. PubMed ID: 23506790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.